Aayush Wellness Enters India''s Rs. 18,913 Cr Respiratory Healthcare Market with Lung Care Tablets for Smoking-Exposed and Respiratory-Concerned Consumers.

August 29, 2026 BSE Limited, Metropolitan Stock Exchange of India Limited, 20th Floor, P. J. Towers, Vibgyor Towers, 4th floor, Plot No C 62, G - Block, Dalal Street, Opp. Trident Hotel, Bandra Kurla Complex, Bandra Mumbai – 400 001. (E), Mumbai – 400 098 (Scrip Code: 539528; Scrip Id: AAYUSH) (Symbol – AAYUSH, Series – EQ) Dear Sir/Madam, Reference: Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. Subject: Press Release: Aayush Wellness Enters India’s ₹18,913 Cr Respiratory Healthcare Market with Lung Care Tablets for Smoking-Exposed and Respiratory-Concerned Consumers This is to inform the Exchange that Aayush Wellness Limited has launched “Lung Care Tablets”, marking a significant expansion of its prevention-led healthcare vision and strengthening its focus on respiratory wellness. The detailed press release titled “Aayush Wellness Enters India’s ₹18,913 Cr. Respiratory Healthcare Market with Lung Care Tablets for Smoking-Exposed and Respiratory-Concerned Consumers” is enclosed herewith, and the contents thereof are self-explanatory. You are requested to take the above cited information on your record. Thanking You, For Aayush Wellness Limited Naveenakumar Kunjaru Managing Director DIN: 07087891 AAYUSH WELLNESS LIMITED CIN: L01122MH1984PLC463364 Registered Office: B402, Takshashila, Samant Estate, Goregaon East, Mumbai – 400063. Contact No: +91 8448693031 Email: cs@aayushwellness.com Website: www.aayushwellness.com Aayush Wellness Enters India’s ₹18,913 Cr Respiratory Healthcare Market with Lung Care Tablets for Smoking-Exposed and Respiratory-Concerned Consumers Building on Aayush Herbal Masala’s prevention-led proposition, the Company expands into respiratory wellness to support consumers exposed to smoking, air pollution and everyday environmental stress. Mumbai, August 29, 2026 — Aayush Wellness Limited, an integrated healthcare company focused on preventive wellness and nutraceutical solutions, today announced the launch of its Lung Care Tablets, marking a significant expansion of its prevention- led healthcare vision. Building on the proposition of Aayush Herbal Masala, developed around the health concerns associated with smokeless-tobacco consumption, the Company is now extending its focus to respiratory wellness, addressing the growing health challenges associated with smoking, air pollution and environmental exposure. The launch comes at a time when India's respiratory healthcare segment represents a significant and growing market. The Respiratory System therapeutic segment recorded sales of ₹18,912.64 crore in 2025, up from ₹17,199.40 crore in 2024, representing approximately 10% YoY growth. With India accounting for 30.28% of global deaths from respiratory diseases, Aayush Wellness sees an opportunity to build a differentiated position in the emerging preventive respiratory-wellness category. Aayush Wellness’ vision is centred on building a prevention-led healthcare platform that proactively addresses the evolving health risks faced by consumers. This vision is reflected in the Company’s approach to product development, identifying a meaningful health risk, understanding the need for intervention and creating an accessible wellness solution around it. Aayush Herbal Masala represented this approach by addressing health concerns associated with smokeless-tobacco consumption. The launch of Lung Care Tablets now carries the same philosophy forward, addressing respiratory-health risks associated with smoking, air pollution and environmental exposure. This progression demonstrates the Company’s intent to build a broader, health-risk-led portfolio, with each new category strengthening its presence across India’s growing preventive healthcare landscape. AAYUSH WELLNESS LIMITED CIN: L01122MH1984PLC463364 Registered Office: B402, Takshashila, Samant Estate, Goregaon East, Mumbai – 400063. Contact No: +91 8448693031 Email: cs@aayushwellness.com Website: www.aayushwellness.com A Large and Growing Respiratory Health Need India faces a significant burden of chronic respiratory diseases. According to the Global Burden of Disease data cited by the Company, India accounts for 15.69% of global chronic respiratory disease cases and 30.28% of global deaths from these conditions. The scale of the challenge highlights the growing need for preventive approaches to respiratory wellness. The issue is particularly relevant in India's urban centers, where exposure to air pollution, smoking, occupational pollutants, and post-viral respiratory complications has increased consumer awareness around lung health. Against this backdrop, Aayush Wellness is positioning Lung Care Tablets as a daily wellness solution focused on supporting respiratory health, complementing the Company's broader portfolio of preventive-health products. Science-Backed Formulation for Everyday Respiratory Wellness Aayush Lung Care Tablets are formulated with a combination of N-Acetyl Cysteine (NAC), Vasaka Extract, Licorice, Quercetin, Vitamin C, Vitamin D2 and Zinc, bringing together ingredients associated with respiratory and immune-support applications. The formulation is designed to support: • Respiratory wellness and lung function • Healthy airway function • Antioxidant and immune support • Healthy inflammatory response • Overall lung-health maintenance By combining herbal ingredients with established nutritional and functional ingredients, the product is designed to address the growing consumer preference for preventive, convenient, and wellness- oriented healthcare solutions. “Our vision has always extended beyond individual products. With Aayush Herbal Masala, we addressed an important consumer health concern associated with smokeless-tobacco consumption. With Lung Care Tablets, we are extending this same prevention-led philosophy to respiratory wellness, where smoking, air pollution and environmental exposure are creating an increasingly important health challenge.” — Naveenakumar Kunjaru, Managing Director, Aayush Wellness Limited The addition of Lung Care Tablets further strengthens Aayush Wellness' nutraceutical portfolio and provides the Company with an opportunity to increase product depth, address additional consumer health needs and create cross-selling opportunities across its existing customer base. By consistently addressing real and rising health concerns with targeted, Ayurvedic-based solutions, Aayush Wellness is strengthening consumer trust and expanding our footprint in the preventive healthcare space. This strategic momentum not only reinforces the brand's purpose but also enhances long-term value creation for the investors through sustained innovation and relevance in a growing market. AAYUSH WELLNESS LIMITED CIN: L01122MH1984PLC463364 Registered Office: B402, Takshashila, Samant Estate, Goregaon East, Mumbai – 400063. Contact No: +91 8448693031 Email: cs@aayushwellness.com Website: www.aayushwellness.com About Aayush Wellness Limited: (ISO 9000 and 22000 certified company) Aayush Wellness Limited [BSE scrip code: 539528, MSEI Symbol – AAYUSH], established in 1984, is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation. We are India’s preventive healthcare company committed to offering quality products and services to enhance the consumer well-being. Aayush Wellness continues to lead the industry in promoting healthier lifestyle choices through its diverse range of wellness products and services. For more information, please visit www.aayushwellness.com or Call: 8655611700 for business inquiries. AAYUSH WELLNESS LIMITED CIN: L01122MH1984PLC463364 Registered Office: B402, Takshashila, Samant Estate, Goregaon East, Mumbai – 400063. Contact No: +91 8448693031 Email: cs@aayushwellness.com Website: www.aayushwellness.com